Literature DB >> 19592498

Pro-interleukin (IL)-1beta shares a core region of stability as compared with mature IL-1beta while maintaining a distinctly different configurational landscape: a comparative hydrogen/deuterium exchange mass spectrometry study.

Kendra L Hailey1, Sheng Li, Mette D Andersen, Melinda Roy, Virgil L Woods, Patricia A Jennings.   

Abstract

Interleukin-1beta (IL-1beta) is a master cytokine involved in initiating the innate immune response in vertebrates (Dinarello, C. A. (1994) FASEB J. 8, 1314-1325). It is first synthesized as an inactive 269-residue precursor (pro-interleukin-1beta or pro-IL-1beta). Pro-IL-1beta requires processing by caspase-1 to generate the active, mature 153-residue cytokine. In this study, we combined hydrogen/deuterium exchange mass spectrometry, circular dichroism spectroscopy, and enzymatic digestion comparative studies to investigate the configurational landscape of pro-IL-1beta and the role the N terminus plays in modulating the landscape. We find that the N terminus keeps pro-IL-1beta in a protease-labile state while maintaining a core region of stability in the C-terminal region, the eventual mature protein. In mature IL-1beta, this highly protected region maps back to the area protected earliest in the NMR studies characterizing an on-route kinetic refolding intermediate. This protected region also encompasses two important functional loops that participate in the IL-1beta/receptor binding interface required for biological activity. We propose that the purpose of the N-terminal precursor region in pro-IL-1beta is to suppress the function of the eventual mature region while keeping a structurally and also functionally important core region primed for the final folding into the native, active state of the mature protein. The presence of the self-inhibiting precursor region provides yet another layer of regulation in the life cycle of this important cytokine.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19592498      PMCID: PMC2758013          DOI: 10.1074/jbc.M109.027375

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  71 in total

1.  Extracting function from a beta-trefoil folding motif.

Authors:  Shachi Gosavi; Paul C Whitford; Patricia A Jennings; José N Onuchic
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-23       Impact factor: 11.205

2.  Backtracking on the folding landscape of the beta-trefoil protein interleukin-1beta?

Authors:  Dominique T Capraro; Melinda Roy; José N Onuchic; Patricia A Jennings
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-19       Impact factor: 11.205

3.  Structure-function mapping of interleukin 1 precursors. Cleavage leads to a conformational change in the mature protein.

Authors:  D J Hazuda; J Strickler; P Simon; P R Young
Journal:  J Biol Chem       Date:  1991-04-15       Impact factor: 5.157

4.  High-resolution three-dimensional structure of interleukin 1 beta in solution by three- and four-dimensional nuclear magnetic resonance spectroscopy.

Authors:  G M Clore; P T Wingfield; A M Gronenborn
Journal:  Biochemistry       Date:  1991-03-05       Impact factor: 3.162

Review 5.  Analysis of fish IL-1beta and derived peptide sequences indicates conserved structures with species-specific IL-1 receptor binding: implications for pharmacological design.

Authors:  Antonis I Koussounadis; David W Ritchie; Graham J L Kemp; Chris J Secombes
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

6.  Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages.

Authors:  Mihai G Netea; Claudia A Nold-Petry; Marcel F Nold; Leo A B Joosten; Bastian Opitz; Jonathan H M van der Meer; Frank L van de Veerdonk; Gerben Ferwerda; Bas Heinhuis; Isabel Devesa; C Joel Funk; Robert J Mason; Bart Jan Kullberg; Anna Rubartelli; Jos W M van der Meer; Charles A Dinarello
Journal:  Blood       Date:  2008-12-22       Impact factor: 22.113

7.  IL-1-converting enzyme requires aspartic acid residues for processing of the IL-1 beta precursor at two distinct sites and does not cleave 31-kDa IL-1 alpha.

Authors:  A D Howard; M J Kostura; N Thornberry; G J Ding; G Limjuco; J Weidner; J P Salley; K A Hogquist; D D Chaplin; R A Mumford
Journal:  J Immunol       Date:  1991-11-01       Impact factor: 5.422

8.  A phospholipid substrate molecule residing in the membrane surface mediates opening of the lid region in group IVA cytosolic phospholipase A2.

Authors:  John E Burke; Yuan-Hao Hsu; Raymond A Deems; Sheng Li; Virgil L Woods; Edward A Dennis
Journal:  J Biol Chem       Date:  2008-08-27       Impact factor: 5.157

9.  Determination of the secondary structure and molecular topology of interleukin-1 beta by use of two- and three-dimensional heteronuclear 15N-1H NMR spectroscopy.

Authors:  P C Driscoll; A M Gronenborn; P T Wingfield; G M Clore
Journal:  Biochemistry       Date:  1990-05-15       Impact factor: 3.162

10.  Rapid and specific conversion of precursor interleukin 1 beta (IL-1 beta) to an active IL-1 species by human mast cell chymase.

Authors:  H Mizutani; N Schechter; G Lazarus; R A Black; T S Kupper
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

View more
  11 in total

1.  Association of the Precursor of Interleukin-1β and Peritoneal Inflammation-Role in Pathogenesis of Endometriosis.

Authors:  Justyna Sikora; Aleksandra Mielczarek-Palacz; Zdzisława Kondera-Anasz
Journal:  J Clin Lab Anal       Date:  2016-03-28       Impact factor: 2.352

2.  Regulating SR protein phosphorylation through regions outside the kinase domain of SRPK1.

Authors:  Ryan M Plocinik; Sheng Li; Tong Liu; Kendra L Hailey; Jennifer Whitesides; Jennifer Whitehouse; Chen-Ting Ma; Xiang-Dong Fu; Gourisankar Gosh; Virgil L Woods; Patricia A Jennings; Joseph A Adams
Journal:  J Mol Biol       Date:  2011-05-13       Impact factor: 5.469

3.  Microglial Heparan Sulfate Proteoglycans Facilitate the Cluster-of-Differentiation 14 (CD14)/Toll-like Receptor 4 (TLR4)-Dependent Inflammatory Response.

Authors:  Paul O'Callaghan; Jin-Ping Li; Lars Lannfelt; Ulf Lindahl; Xiao Zhang
Journal:  J Biol Chem       Date:  2015-04-13       Impact factor: 5.157

4.  Allosteric switching of agonist/antagonist activity by a single point mutation in the interluekin-1 receptor antagonist, IL-1Ra.

Authors:  Kendra L Hailey; Dominique T Capraro; Sulyman Barkho; Patricia A Jennings
Journal:  J Mol Biol       Date:  2013-03-15       Impact factor: 5.469

5.  Integrated strategy reveals the protein interface between cancer targets Bcl-2 and NAF-1.

Authors:  Sagi Tamir; Shahar Rotem-Bamberger; Chen Katz; Faruck Morcos; Kendra L Hailey; John A Zuris; Charles Wang; Andrea R Conlan; Colin H Lipper; Mark L Paddock; Ron Mittler; José N Onuchic; Patricia A Jennings; Assaf Friedler; Rachel Nechushtai
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-25       Impact factor: 11.205

6.  An innate interaction between IL-18 and the propeptide that inactivates its precursor form.

Authors:  Naotaka Tsutsumi; Ayumi Yokota; Takeshi Kimura; Zenichiro Kato; Toshiyuki Fukao; Masahiro Shirakawa; Hidenori Ohnishi; Hidehito Tochio
Journal:  Sci Rep       Date:  2019-04-16       Impact factor: 4.379

7.  Post-translational control of IL-1β via the human papillomavirus type 16 E6 oncoprotein: a novel mechanism of innate immune escape mediated by the E3-ubiquitin ligase E6-AP and p53.

Authors:  Martina Niebler; Xu Qian; Daniela Höfler; Vlada Kogosov; Jittranan Kaewprag; Andreas M Kaufmann; Regina Ly; Gerd Böhmer; Rainer Zawatzky; Frank Rösl; Bladimiro Rincon-Orozco
Journal:  PLoS Pathog       Date:  2013-08-01       Impact factor: 6.823

8.  Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation.

Authors:  E Suzanne Cohen; Ian C Scott; Jayesh B Majithiya; Laura Rapley; Benjamin P Kemp; Elizabeth England; D Gareth Rees; Catherine L Overed-Sayer; Joanne Woods; Nicholas J Bond; Christel Séguy Veyssier; Kevin J Embrey; Dorothy A Sims; Michael R Snaith; Katherine A Vousden; Martin D Strain; Denice T Y Chan; Sara Carmen; Catherine E Huntington; Liz Flavell; Jianqing Xu; Bojana Popovic; Christopher E Brightling; Tristan J Vaughan; Robin Butler; David C Lowe; Daniel R Higazi; Dominic J Corkill; Richard D May; Matthew A Sleeman; Tomas Mustelin
Journal:  Nat Commun       Date:  2015-09-14       Impact factor: 14.919

9.  HMGB1/IL-1β complexes in plasma microvesicles modulate immune responses to burn injury.

Authors:  Leon G Coleman; Robert Maile; Samuel W Jones; Bruce A Cairns; Fulton T Crews
Journal:  PLoS One       Date:  2018-03-30       Impact factor: 3.240

10.  Redefining the ancestral origins of the interleukin-1 superfamily.

Authors:  Jack Rivers-Auty; Michael J D Daniels; Isaac Colliver; David L Robertson; David Brough
Journal:  Nat Commun       Date:  2018-03-20       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.